⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MCRB News
Seres Therapeutics, Inc.
Form 8-K
sec.gov
MCRB
Form 8-K
sec.gov
MCRB
Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
globenewswire.com
MCRB
Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
globenewswire.com
MCRB
Form 8-K
sec.gov
MCRB
Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates
globenewswire.com
MCRB
Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates
globenewswire.com
MCRB
Seres Provides Program and Corporate Updates and Prioritizes Emerging Programs in Inflammatory & Immune Diseases
globenewswire.com
MCRB
Particles for Humanity Appoints Marcus Chapman as Senior Vice President and Head of Finance
prnewswire.com
MCRB
Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst™ Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy
globenewswire.com
MCRB